MediXall Group, Inc. financial data

Location
104 N 4 Th St., Leesburg, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Sep 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.69 % +171%
Debt-to-equity -104 % +8.51%
Return On Equity 35.1 % -67.5%
Return On Assets -938 % -16.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 206M shares
Common Stock, Shares, Outstanding 169M shares +29.4%
Entity Public Float 95.9K USD
Common Stock, Value, Issued 169K USD +29.4%
Weighted Average Number of Shares Outstanding, Basic 162M shares +24.4%
Weighted Average Number of Shares Outstanding, Diluted 162M shares +24.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 304K USD +29.4%
Cost of Revenue 130K USD -30.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.16M USD +55.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.16M USD +55.8%
Earnings Per Share, Basic 0 USD/shares +80%
Earnings Per Share, Diluted 0 USD/shares +80%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 3.48K USD 0%
Assets, Current 46.9K USD +257%
Property, Plant and Equipment, Net 10.7K USD -26.9%
Operating Lease, Right-of-Use Asset 17.7K USD
Intangible Assets, Net (Excluding Goodwill) 34.1K USD -88.3%
Assets 220K USD -51.7%
Accrued Liabilities, Current 1.11M USD
Liabilities, Current 3.79M USD -33.5%
Operating Lease, Liability, Noncurrent 5.98K USD
Liabilities 3.84M USD -32.7%
Retained Earnings (Accumulated Deficit) -39M USD -9.16%
Stockholders' Equity Attributable to Parent -3.62M USD +31.1%
Liabilities and Equity 220K USD -51.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -309K USD +31.1%
Net Cash Provided by (Used in) Financing Activities 352K USD -21.3%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 169M shares +29.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31.9K USD +230%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 8.76M USD +15.7%
Operating Lease, Liability 0 USD -100%
Operating Lease, Liability, Current 11.7K USD
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -107%
Deferred Tax Assets, Operating Loss Carryforwards 6.88M USD +12.8%
Additional Paid in Capital 35.2M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 443K USD